Raising Awareness: World Kidney Cancer Day 2020
Adrian Hayes2020-07-23T16:02:31-04:00On June 18th, people from all around the world came together to participate in activities for #WorldKidneyCancerDay,
Virtual Town Hall: Tuesday, May 19th at 6:00 ET
Adrian Hayes2020-05-15T18:15:57-04:00Kidney Cancer in the Time of COVID-19 We're excited to share this opportunity for those in the kidney cancer community
KCRS White Paper Published by JNCI
Adrian Hayes2020-05-04T19:15:12-04:00Big News! We are thrilled to announce that our white paper of the 2019 Kidney Cancer Research Summit (KCRS) was
Raising Our Voices: KidneyCAN Advocates in Washington D.C.
Adrian Hayes2020-03-11T13:21:26-04:00On March 9th and 10th, KidneyCAN delegates from all over the country gathered in Washington, D.C., to lift their voices on
Education & Advocacy at the DF/HCC Kidney Cancer Symposium
Adrian Hayes2020-03-07T16:49:30-05:00It was an inspiring day in Boston! More than 80 delegates attended live and dozens more live-streamed the presentations at the
A Patient-Advocate’s Perspective: ASCO GU 2020
Adrian Hayes2020-02-28T15:06:49-05:00Howard McClurd is a kidney cancer patient and advocate. Here are his thoughts from the 2020 ASCO GU Symposium. The first impression
This Week: RADVAX at ASCO GU
Adrian Hayes2020-02-13T16:56:31-05:00We are so proud to see Dr. Hans Hammers's clinical trial of RADVAX selected for presentation at ASCO GU 2020. ASCO is
What Kidney Cancer Research Looks Like: SUNY Upstate Medical University
Bryan Lewis2020-02-11T17:15:28-05:00In January, the KidneyCAN team traveled to Syracuse, New York to visit the SUNY (State University of New York) Upstate Medical
A New Era for the FDA: Our Perspective
Adrian Hayes2020-02-05T16:55:22-05:00In the past, the work of the Food and Drug Administration was often bogged down by bureaucratic processes and the red tape
Clinical Trials Save Lives: Gary’s RADVAX Story
Adrian Hayes2020-01-24T14:25:17-05:00January is Clinical Trial Awareness Month. Today, we're featuring a story from Gary Cole, our friend and a kidney cancer patient. He